Blas Gil Extremera-rekin lankidetzan egindako argitalpenak (3)

2013

  1. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus

    JAMA Internal Medicine, Vol. 173, Núm. 18, pp. 1682-1692

2008

  1. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

    The Lancet, Vol. 372, Núm. 9644, pp. 1174-1183

  2. Telmisartan, ramipril, or both in patients at high risk for vascular events

    New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559